Kate Chasmar

Kate Chasmar has extensive experience in the field of pharmacovigilance. Kate currently holds the position of Head of Pharmacovigilance at Quanticate since June 2023. Prior to this, they worked at Cmed Clinical Services from 2013 to 2023, holding various roles including Senior Manager, Pharmacovigilance and Manager, Pharmacovigilance. Kate also worked at PrimeVigilance Ltd from 2011 to 2013 as a Pharmacovigilance Officer. Kate started their career at Novartis in 2007, where they held positions such as Clinical Safety Associate and Safety Data Associate.

Kate Chasmar attended the University of Surrey from 2003 to 2006, where they earned a Bachelor of Science (BSc) degree in Physics.